Consolidated Statements of Changes In Shareholders' Equity - USD ($) $ in Thousands		Total	Cumulative Effect, Period of Adoption, Adjustment	[4]	Common Stock	Additional Paid-in Capital	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	[4]	Accumulated Other Comprehensive (Loss) Income	Treasury Stock
Beginning balance (in shares) at Dec. 31, 2020					8,511,835
Beginning balance at Dec. 31, 2020		$ 255,688			$ 8,512	$ 178,853	$ 70,175			$ (57)	$ (1,795)
Net income		29,319					29,319
Total other comprehensive loss, net of taxes		215								215
Common stock dividends declared		(8,451)					(8,451)
Common shares issued through follow-on public offering, net of underwriting discounts and offering expenses (in shares)	[1]				2,990,000
Common shares issued through follow-on public offering, net of underwriting discounts and offering expenses	[1]	70,238			$ 2,990	67,248
Common stock issued to shareholders in acquisition (in shares)	[2]				4,519,776
Common stock issued to shareholders in acquisition	[2]	142,192			$ 4,520	137,672
Repurchased stock		(128)									(128)
Employee Stock Purchase Plan (in shares)					6,066
Employee Stock Purchase Plan		172			$ 6	166
Director Stock Purchase Plan (in shares)					4,771
Director Stock Purchase Plan		135			$ 5	130
Restricted stock activity (in shares)					23,834
Restricted stock activity		696			$ 23	673
Ending balance (in shares) at Dec. 31, 2021					16,056,282
Ending balance at Dec. 31, 2021		490,076			$ 16,056	384,742	91,043			158	(1,923)
Net income		54,806					54,806
Total other comprehensive loss, net of taxes		(19,374)								(19,374)
Common stock dividends declared		(12,735)					(12,735)
Common stock issued to shareholders in acquisition	[3]	776				776
Repurchased stock		(2,957)									(2,957)
Employee Stock Purchase Plan (in shares)					7,152
Employee Stock Purchase Plan		200			$ 7	193
Director Stock Purchase Plan (in shares)					5,876
Director Stock Purchase Plan		165			$ 6	159
Restricted stock activity (in shares)					25,176
Restricted stock activity		1,142			$ 25	1,117
Ending balance (in shares) at Dec. 31, 2022					16,094,486
Ending balance at Dec. 31, 2022		512,099	$ (11,548)		$ 16,094	386,987	133,114	$ (11,548)		(19,216)	(4,880)
Net income		37,397					37,397
Total other comprehensive loss, net of taxes		2,579								2,579
Common stock dividends declared		(12,981)					(12,981)
Common stock issued to shareholders in acquisition (in shares)	[5]				849,510
Common stock issued to shareholders in acquisition	[5]	18,095			$ 850	17,245
Repurchased stock	[6]	(4,876)				(37)					(4,839)
Employee Stock Purchase Plan (in shares)					13,459
Employee Stock Purchase Plan		303			$ 13	290
Director Stock Purchase Plan (in shares)					7,884
Director Stock Purchase Plan		179			$ 8	171
Restricted stock activity (in shares)					33,590
Restricted stock activity		1,103			$ 34	1,069
Ending balance (in shares) at Dec. 31, 2023					16,998,929
Ending balance at Dec. 31, 2023		$ 542,350			$ 16,999	$ 405,725	$ 145,982			$ (16,637)	$ (9,719)

[1] Shares issued in offering were net of expenses of $4.6 million.

[2] Shares issued as a result of the acquisition of Riverview Financial Corporation ("Riverview").

[3] Additionally, 2,500 shares of restricted stock were paid out in cash resulting in $776 thousand of cash consideration relating to stock awards.

[4] The Corporation adopted ASU 2016-13 "Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments" effective January 1, 2023. See "Note 1 - Summary of Significant Accounting Policies" for further details.

[5] Shares issued as a result of the acquisition of Brunswick Bancorp ("Brunswick"). See "Note 2 - Business Combinations", to the Consolidated Financial Statements for more information.

[6] Includes tax effects of repurchased stock.